Atlas Trials

Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer

Clinical trial NCT00636883 · TERMINATED

Trial details

NCT number
NCT00636883
Sponsor
National Guard Health Affairs
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2008-01-01
Primary completion
2012-07-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.